Edgewell Personal Care (EPC) director granted 7,817 restricted stock equivalents

Rhea-AI Filing Summary

Edgewell Personal Care Company director equity grant

Edgewell Personal Care Company reported that director Gary Waring received an award of 7,817 restricted stock equivalents on February 5, 2026. These derivative securities were granted at a price of $0 per unit and are held in his direct ownership.

The restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless Waring elects to defer conversion until his service on Edgewell’s Board of Directors ends. After this grant, he beneficially owns 7,817 restricted stock equivalents.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Waring Gary

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Equivalents 2-5-2026	7,817	$0.00	--

Holdings After Transaction: Restricted Stock Equivalents 2-5-2026 — 7,817 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Waring Gary

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 2-5-2026	$0	02/05/2026		A		7,817		(1)	(1)	Common Stock	7,817	$0	7,817	D

Explanation of Responses:

1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

	/s/ LaTanya Langley	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Edgewell Personal Care (EPC) report for Gary Waring?

Edgewell Personal Care reported that director Gary Waring received 7,817 restricted stock equivalents on February 5, 2026. The Form 4 shows the award at a price of $0 per unit, held directly, increasing his beneficial holdings to 7,817 derivative securities.

How many restricted stock equivalents did EPC director Gary Waring receive?

Director Gary Waring received 7,817 restricted stock equivalents in this reported transaction. The Form 4 indicates these derivative securities were acquired at a price of $0 per unit and are now all beneficially owned directly following the grant.

When do Gary Waring’s restricted stock equivalents in Edgewell Personal Care convert to common stock?

The restricted stock equivalents convert into Edgewell common stock on the day preceding the next annual meeting of shareholders. However, Gary Waring may elect to defer this conversion until his service on Edgewell’s Board of Directors terminates, according to the footnote.

What is the exercise or conversion price of Gary Waring’s restricted stock equivalents at EPC?

The reported conversion price of Gary Waring’s restricted stock equivalents is $0 per unit. The Form 4 lists 7,817 derivative securities acquired at this price, reflecting a compensatory equity award rather than an open-market purchase for cash consideration.

Is Gary Waring’s ownership of the reported EPC restricted stock equivalents direct or indirect?

Gary Waring’s ownership of the 7,817 restricted stock equivalents is reported as direct. The Form 4 indicates the ownership form as “D” for direct, with no footnote shifting voting or investment power to any trust, partnership, or other related entity.